Proximal Seal After Endovascular Aneurysm Repair: Why Sealing Length Dynamics and Type 2 Endoleak Matter - Scorecard - MDSpire

Proximal Seal After Endovascular Aneurysm Repair: Why Sealing Length Dynamics and Type 2 Endoleak Matter

  • By

  • Giulio Accarino

  • Raffaele Pulli

  • Felice Pecoraro

  • Domenico Angiletta

  • Nabile Belouafa

  • Salvatore Bruno

  • Stefano Attolini

  • Francesca Noce

  • Mostafa El Moumni

  • Jean-Paul P. M. de Vries

  • Umberto Marcello Bracale

  • July 6, 2026

  • 0 min

Share

Clinical Scorecard: Dynamics of Sealing Length and Type 2 Endoleak in Proximal Sealing Following Endovascular Aneurysm Repair

At a Glance

CategoryDetail
ConditionInfrarenal Abdominal Aortic Aneurysm (AAA)
Key MechanismsProximal sealing changes and endoleak dynamics post-EVAR
Target PopulationPatients undergoing elective or urgent EVAR for fusiform infrarenal AAA
Care SettingMulticenter retrospective study

Key Highlights

  • EVAR is the predominant treatment for infrarenal AAA with lower peri-operative morbidity than open repair.
  • Type 2 endoleak (EL2) is the most frequent endoleak after EVAR, with varying clinical significance.
  • Proximal sealing length (SL) changes post-EVAR are associated with later EL1A occurrences.
  • Structured follow-up is emphasized to detect endoleaks and seal-related complications.
  • Loss of proximal sealing can increase rupture risk.

Guideline-Based Recommendations

Diagnosis

  • Routine computed tomography angiography (CTA) within 1 month and at 1 year post-EVAR.

Management

  • Surveillance protocols should include clinical assessment and imaging at least annually.

Monitoring & Follow-up

  • Monitor for endoleaks, sac enlargement, migration, and seal-related complications.

Risks

  • Loss of proximal sealing leading to type 1A endoleak increases rupture risk.

Patient & Prescribing Data

Consecutive patients with fusiform infrarenal AAA undergoing EVAR.

Inclusion criteria focused on degenerative pathology; exclusion of non-degenerative conditions.

Clinical Best Practices

  • Follow a standardized protocol for assessing CTAs based on defined criteria.
  • Evaluate sealing metrics longitudinally rather than relying on a single measurement.

Related Resources & Content

Original Source(s)

Related Content